Naltrexone Completed Phase 3 Trials for Disseminated Sclerosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00501696A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone